Featured Articles

  1. Driving Biologics Formulation Through Digital, In Silico Transformation 1/21/2026

    AI, ML, NLP, and other in‑silico tools are transforming biologics formulation by enabling earlier risk assessment, better formulatability predictions, and faster preclinical workflows.

  2. Advancing Subvisible Particle Characterization With AI 1/14/2026

    An advanced approach leveraging artificial intelligence identifies the root causes of aggregation, streamlining formulation development and ensuring consistent product quality across every batch.

  3. Formulation Development Experience For Effective Particle Identification 1/14/2026

    Combining advanced analytics with deep formulation knowledge enables precise root-cause analysis, preventing manufacturing delays and ensuring that products remain high-quality and safe for patients.